BLS AG

Biovail to Acquire Rights to Develop, Commercialize JP-1730/Fipamezole in North America from Santhera.
Biotech Week; 9/9/2009; 923 words; ...that its subsidiary, Biovail Laboratories International SRL (BLS), has entered into an agreement with Santhera Pharmaceuticals...Switzerland) Ltd., a subsidiary of Santhera Pharmaceuticals Holding AG (SIX: SANN) to acquire the U.S. and Canadian rights to...

Economy at a glance.(facts figures & trends)(Statistical table)(Brief article)
PT: Magazine of Physical Therapy; 9/1/2009; 722 words; ...3-month percent change (7) Output per hour, nonfarm business, percent change from previous quarter at annual rate + 1st Quarter Source: Bureau of Labor Statistics, Department of Labor. Available of www.bls.gov/eag/ag.us.htm

Biovail to Purchase Rights to Develop and Commercialize JP-1730/Fipamezole in North America.
Health & Beauty Close-Up; 8/25/2009; 1155 words; ...Biovail Laboratories International SRL (BLS), has entered into an agreement with Santhera...subsidiary of Santhera Pharmaceuticals Holding AG, to acquire the U.S. and Canadian rights...products. Santhera Pharmaceuticals Holding AG is a Swiss specialty pharmaceutical company...

News and FDA Updates for Biovail (NYSE:BVF), BrainStorm (OTC:BCLI), Tikcro (OTC:TIKRF), IDenta (OTC:IDTA).
M2 Presswire; 8/25/2009; 1129 words; ...announced its subsidiary, Biovail Laboratories International SRL (BLS), has entered into an agreement with Santhera Pharmaceuticals...Switzerland) Ltd., a subsidiary of Santhera Pharmaceuticals Holding AG (SIX: SANN) to acquire the U.S. and Canadian rights to...

CRWENews.com Highlights: BVF, NPD, BDC, TSM.
M2 Presswire; 8/24/2009; 1046 words; ...that its subsidiary, Biovail Laboratories International SRL (BLS), has entered into an agreement with Santhera Pharmaceuticals...Switzerland) Ltd., a subsidiary of Santhera Pharmaceuticals Holding AG (SIX: SANN) to acquire the U.S. and Canadian rights to...